期刊文献+

茵陈越鞠汤联合托尼萘酸治疗非酒精性脂肪肝 被引量:6

Combined Yinchen Yueju decoction with GALLE-DONAU treatment for nonalcoholic fatty liver disease
下载PDF
导出
摘要 目的观察茵陈越鞠汤联合托尼萘酸中西医结合治疗非酒精性脂肪肝的效果。方法将60例患者随机分为2组,各30例,2组均口服托尼萘酸片,治疗组加服中药茵陈越鞠汤(茵陈、大黄、栀子、苍术、香附、神曲等),3月为1个疗程,连续服用1疗程。结果治疗组总有效率90.00%,优于对照组的76.67%(P<0.05)。结论茵陈越鞠汤联合托尼萘酸治疗非酒精性脂肪肝可发挥治病求本、增效减毒的中西医结合优势,有效改善临床症状。 Objective Observation the effect of Combined Yinchen Yueju decoction and GALLEA-DONAU for nonalcoholic fatty liver disease. Methods The 60 patients were randomly assigned into two groups of 30,as control group and observation group,both taking oral medicine of GALLE-DONAU,observation group also taking Chinese medicine of Yinchen Yueju decoction( Yinchen,rhubarb,gardenia,rhizoma atractylodis,rhizoma cyperi,medicated leaven etc.),3 months for one treatment course. Results The treatment group total effective rate was 90. 00%,the effect of observation group is better than control group's 76. 67%( P〈0. 05). Conclusion The effect of combined treatment of Yinchen Yueju decoction and GALLE-DONAU for nonalcoholic fatty liver disease is satisfied,effectively improve the clinical symptoms.
出处 《长春中医药大学学报》 2015年第1期126-128,共3页 Journal of Changchun University of Chinese Medicine
基金 深圳市宝安区科技计划社会公益项目(2013213)
关键词 非酒精性脂肪肝/中西医结合疗法 茵陈越鞠汤 托尼萘酸 nonalcoholic fatty liver disease / combined treatment of Chinese and western medicine Yinchen Yueju decoction GALLE-DONAU
  • 相关文献

参考文献11

二级参考文献88

共引文献263

同被引文献90

  • 1张姝娜,崔丽,刘洪艳,韩永辉.托尼萘酸片治疗酒精性肝病的临床疗效[J].实用药物与临床,2005,8(3):28-30. 被引量:5
  • 2王纯正,徐智章.超声诊断学[M].北京:人民卫生出版社,2004:393-395.
  • 3李志颖,钱秋海.糖尿病合并非酒精性脂肪肝的中西医治疗进展[J].生物医学工程研究,2013,32(1) :65-68.
  • 4Sun WM, Wang YP,Duan YQ, et al. Radix Hedysaripolysaccharide suppresses lipid metabolism dysfunction in a ratmodel of non-alcoholic fatty liver disease via adenosinemonophosphateactivated protein kinase pathway activation[J]. Mol Med Rep,2014,10(3) :1237-1244.
  • 5Black LJ? Jacoby P,She Ping-Delfos WC, et al. Low serum25-hydroxyvitamin D concentrations associate with non-alcoholic fatty liver disease in adolescents independent ofadiposityCJ]. J Gastroenterol Hepatol, 2014,29 (6): 1215-1222.
  • 6Sahebkar A, Chew GT,Watts GF, et al. New peroxisomeproliferator-Activated receptor agonists: Potential treatmentsfor atherogenic Dyslipidemia and non-Alcoholic fatty liverdisease[J]. Expert Opin Pharmacother,2014,15(4) :493^503.
  • 7髙天舒,晏丽丽,王英娜,等.新诊断2型糖尿病合并非酒精性脂肪肝中西医发病机制的研究[C]//第三次全国中西医结合内分泌代谢病学术大会暨糖尿病论坛论文集,2010:226-230.
  • 8向国卿,孟宪云,张浩,台文霞,孟晓丹,王炳元.脂肪肝相关危险因素的评估[J].世界华人消化杂志,2009,17(10):1038-1041. 被引量:69
  • 9张冰,郑友丽,张英凯.降脂软肝汤治疗非酒精性脂肪肝38例疗效观察[J].吉林中医药,2009,29(8):678-679. 被引量:4
  • 10孟胜喜.针刺治疗非酒精性脂肪性肝炎疗效观察[J].中国针灸,2009,29(8):616-618. 被引量:25

引证文献6

二级引证文献38

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部